Warfarin
21 spontaneous reports of increased INR with glucosamine use in WHO database.
Recommendation: Monitor INR more frequently when starting or stopping glucosamine in warfarin patients.
Other ·Moderate evidence ·Reviewed May 2026
Amino sugar building block for cartilage repair and joint health.
The bottom line
Evidence rating moderate. Most-documented uses: joint health, cartilage repair, osteoarthritis relief. 17 sources indexed (2001–2025), with 5 interaction records on file.
Core mechanism
Provides substrate for glycosaminoglycan (GAG) and proteoglycan synthesis in cartilage. Inhibits cartilage-degrading enzymes (MMPs, aggrecanases). Mild anti-inflammatory via NF-κB modulation.3
Take with food; 6-8 weeks for noticeable benefit
Dosing protocol
Sulfate form has stronger evidence than HCl. Effect on osteoarthritis pain takes 12 weeks.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Glucosamine Sulfate / HCl.
Assumes 1,500 mg/day. Vendor basis: NOW/iHerb, Vitacost, Life Extension, and Amazon marketplace; sulfate and combination joint formulas raise cost. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Common foods do not reliably provide supplemental glucosamine amounts.
What to test, the optimal window inside the conventional range, and how long a response takes.
Glucosamine sulfate (1500 mg per day) modestly lowers hsCRP in cohort and small RCT data; clinical effect on osteoarthritis pain is debated but persistent in long-term Rotta-form trials.3,6
Sulfate form has stronger evidence than HCl. Glucosamine HCl plus chondroitin showed no benefit in GAIT trial except in moderate-to-severe pain subgroup.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Supplies a substrate for glycosaminoglycan synthesis in cartilage and may modestly reduce pain and slow joint space narrowing.2,3
Glucosamine sulfate (not hydrochloride) has the better trial data; benefit is modest and inconsistent, best for those who respond within 8 to 12 weeks. Shellfish-derived; check allergy.
Glucosamine is a building block for cartilage glycosaminoglycans and may modestly support joint comfort in osteoarthritis.2,8
Trial results are mixed; allow about 8 weeks. Shellfish derived forms may concern those with shellfish allergy.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Glucosamine is a substrate for glycosaminoglycan and proteoglycan synthesis in cartilage and connective tissue. The evidence is mixed and at best supports joint comfort rather than correcting hypermobility.1,2
21 spontaneous reports of increased INR with glucosamine use in WHO database.
Recommendation: Monitor INR more frequently when starting or stopping glucosamine in warfarin patients.
Co-administration is the most studied combination for osteoarthritis, with potential additive effects on cartilage matrix support and symptomatic joint relief.
Recommendation: These two are commonly and safely taken together. Take as a combined daily dose and allow several weeks to assess symptomatic benefit.
MSM and glucosamine are commonly combined for osteoarthritis, and some trials suggest the pair improves joint pain and function more than either alone, with a good tolerability profile.
Recommendation: Reasonable to combine for joint support. Monitor for mild gastrointestinal upset and continue only if you notice benefit over several weeks.
Both support joint health through the cartilage matrix, with glucosamine providing a substrate for glycosaminoglycan synthesis and hyaluronic acid contributing to synovial fluid viscosity.
Recommendation: Reasonable to combine for joint support. No timing separation needed.
The pair targets joint discomfort through distinct routes, with Boswellia dampening inflammatory signaling and Glucosamine supplying a building block for cartilage matrix, so the combination addresses both inflammation and structural support.
Recommendation: Reasonable to take together for osteoarthritis support. Use a standardized Boswellia extract (for example one enriched for AKBA) at the label dose alongside glucosamine sulfate 1500mg per day. No timing separation is needed.
Numbered references. Citations throughout the page link here.
Baden KER, Hoeksema SL, Gibson N et al.. The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review. Nutrients. 2025
Sivakumar S, Kumar PP, Prasanna PL et al.. Efficiency of Glucosamine in Treating Temporomandibular Joint Osteoarthritis: A Meta-Analytic Umbrella Review. Current rheumatology reviews. 2025
Updated meta-analysis found glucosamine sulfate (but not glucosamine hydrochloride) provided modest but statistically significant reductions in pain and improvement in function in knee osteoarthritis.
Meta-analysis of prospective cohort studies found regular glucosamine use was associated with reduced risk of cardiovascular events and all-cause mortality.
Meta-analysis found the combination of glucosamine and chondroitin was more effective than either alone for pain relief and functional improvement in osteoarthritis.
Rabade A, Viswanatha GL, Nandakumar K et al.. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis. Inflammopharmacology. 2024
Sumsuzzman DM, Khan ZA, Jung JH et al.. Comparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis. Journal of clinical medicine. 2024
Derwich M, Górski B, Amm E et al.. Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review. International journal of molecular sciences. 2023
Glucosamine reduced pain on VAS but had small, non-significant effect on knee function as measured by WOMAC.
Glucosamine and chondroitin, alone or combined, did not reduce joint pain or joint space narrowing compared with placebo in this large network meta-analysis.
In 1,583 knee OA patients randomized over 24 weeks, glucosamine alone did not significantly reduce pain compared with placebo in the overall study population.
Placebo group had progressive joint-space narrowing of -0.31 mm after 3 years, while glucosamine sulfate group had no significant loss (-0.06 mm).
Continuous glucosamine sulfate 1500 mg/day for 3 years significantly reduced progression of joint structure changes vs placebo by radiologic joint space narrowing.
Glucosamine is more effective than placebo at reducing knee OA pain; no reports of serious medication interactions or significant adverse events.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.